U.S. Office REITs Stock News

Somnigroup International (NYSE:SGI) has announced an upcoming Investor Day event. Executive management is expected to outline the company’s vision, growth initiatives, and multi year financial targets. The event is aimed at providing greater clarity on strategy and capital allocation for shareholders and potential investors. Somnigroup International, trading at $96.32, has drawn attention with a 50.7% return over the past year and 211.8% over the past five years. In the shorter term, the...

Dell Technologies (DELL) stock is back in focus after a fresh leadership move in Asia Pacific, Japan & Greater China, along with new partner incentives and steady AI infrastructure demand reshaping expectations. See our latest analysis for Dell Technologies. The leadership reshuffle in Asia Pacific and refreshed partner incentives arrive as Dell’s share price has climbed 4.91% over the last day and 5.78% over the past week. The 1-year total shareholder return of 15.91% contrasts with weaker...

WEX Inc. has already reported fourth-quarter 2025 results, with revenue rising to US$672.9 million and net income to US$84.3 million, while issuing 2026 revenue guidance of US$2.70 billion to US$2.76 billion and first-quarter 2026 guidance of US$650 million to US$670 million. The company’s Benefits and Corporate Payments segments helped drive the earnings beat, but management’s 2026 outlook was restrained, reflecting expectations for lower U.S. retail fuel prices. We’ll now examine how this...

VeriSign (VRSN) has just closed out FY 2025 with fourth quarter revenue of US$425.3 million and basic EPS of US$2.23, rounding out a year in which trailing twelve month revenue came in at US$1.66 billion and EPS at US$8.83. Over the past six quarters, revenue has moved from US$390.6 million in Q3 2024 to US$425.3 million in Q4 2025, while quarterly basic EPS has ranged between US$2.00 and US$2.28, setting the backdrop for trailing net income of US$825.7 million. With net margins staying high...

If you are wondering whether U.S. Physical Therapy is fairly priced or offering room for value, this article is designed to walk you through what the current numbers suggest. The share price recently closed at US$85.58, with returns of 2.0% over 7 days, 7.7% over 30 days, 8.5% year to date, 0.6% over 1 year, a 7.5% decline over 3 years, and a 32.5% decline over 5 years. These mixed return figures sit against a backdrop of ongoing interest in outpatient physical therapy providers in the U.S...

Recent analyst reports on Park Hotels & Resorts (PK) arrived almost back to back, with JP Morgan, Barclays and Truist Securities outlining contrasting views as the company refocuses on domestic assets and refinances upcoming debt. See our latest analysis for Park Hotels & Resorts. The recent 3.2% 1-day and 8.2% 30-day share price returns suggest short term momentum is picking up, even though the 1-year total shareholder return of a 4.1% decline and 5-year total shareholder return of a 16.8%...

Accenture Federal Services, part of NYSE:ACN, has been selected to play a major role in the U.S. Department of Veterans Affairs Electronic Health Record Modernization program. The multi year engagement centers on transforming the healthcare system that serves millions of U.S. veterans through new electronic health record capabilities. Accenture will provide integration and transformation services focused on digital government and healthcare modernization. For you as an investor, this puts...

WisdomTree (NYSE:WT) is expanding its blockchain efforts with regulated tokenized funds now launched on the Solana network. The company is positioning tokenized assets and digital infrastructure as a core part of its business model, beyond traditional ETFs. These moves extend its earlier work in digital assets into a broader push to integrate blockchain with mainstream financial services. For you as an investor, this matters because WisdomTree is not just an ETF issuer anymore; it is...

Nathan's Famous (NATH) has reported Q3 2026 revenue of US$34.3 million with basic EPS of US$0.75, putting the latest quarter against a year when trailing twelve month EPS stands at US$5.24 on revenue of US$157.8 million. Over the past few quarters, the company has seen revenue range from US$30.8 million to US$47.0 million, while basic EPS has moved between roughly US$0.75 and US$2.18, giving investors a clear view of how earnings track against the top line. With a net profit margin of 13.6%...

In late January 2026, The Trade Desk appointed long-time insider Tahnil Davis as interim CFO after Alexander Kayyal’s brief five‑month tenure, while partner Xumo announced new advertiser access to its more than 60 million monthly active streaming users via The Trade Desk’s OpenPath connection through FreeWheel. Together, the abrupt finance leadership change and Xumo’s move to simplify direct access to connected TV inventory highlight the tension between governance stability and product reach...

Health Canada has approved Merck's ENFLONSIA (clesrovimab), a monoclonal antibody for the prevention of respiratory syncytial virus (RSV) in newborns and infants. The decision gives Canadian clinicians a new tool aimed at reducing RSV related illness in a highly vulnerable pediatric group. For investors watching Merck (NYSE:MRK), this approval adds a fresh product to the company's vaccines and biologics portfolio at a time when the stock trades around $121.93. Shares have returned 10.6%...

Recent trading context for Marzetti Marzetti (MZTI) has caught investor attention after a recent stretch of mixed returns, with the share price roughly flat over the past day but negative over the past week, month, and past 3 months. See our latest analysis for Marzetti. Zooming out, Marzetti’s share price has slipped over the past week, month and quarter, and its 1 year total shareholder return of 16.18% decline points to pressure building over a longer stretch. This may reflect shifting...

Health Canada approval puts Yorvipath in focus for Ascendis investors Ascendis Pharma (NasdaqGS:ASND) just received market authorization from Health Canada for Yorvipath, its parathyroid hormone replacement therapy for adults with chronic hypoparathyroidism, bringing a new regulated market into the picture for shareholders. See our latest analysis for Ascendis Pharma. At a share price of $222.15, Ascendis Pharma has seen a 12.34% 90 day share price return and an 83.79% one year total...

AutoNation (AN) has put up a mixed FY 2025 finish, with Q4 revenue at US$6.9b, basic EPS of US$4.70 and net income of US$172.1m, set against trailing twelve month revenue of US$27.6b and EPS of US$17.04. Over recent quarters the company has seen quarterly revenue move from US$7.0b in Q2 2025 to US$6.9b in Q4 2025. Quarterly basic EPS shifted from US$2.29 in Q2 to US$5.72 in Q3 and US$4.70 in Q4, giving investors plenty to weigh up around earnings power and sales momentum. With trailing net...

Aftermath Silver (OTCPK:AAGF.F) has reshaped its senior team by appointing veteran mining engineer Danny Keating as chief operating officer and moving Michael Parker into a focused technical director role across its Peru and Chile projects. See our latest analysis for Aftermath Silver. At a share price of $0.739, Aftermath Silver has seen a 7.93% 1 day share price return and a 47.80% 90 day share price return. Its 1 year total shareholder return of 99.08% and 3 year total shareholder return...

RGC Resources (RGCO) opened Q1 2026 with revenue of US$30.3 million and basic EPS of US$0.48, alongside trailing twelve month EPS of US$1.25 that sits against a 7.3% earnings growth rate over the last year. The company has seen revenue move from US$27.3 million in Q1 2025 to US$30.3 million in Q1 2026, while quarterly EPS went from US$0.51 to US$0.48 over the same period, set against a trailing twelve month net profit margin of 13.1% compared with 13.7% a year earlier. Overall, the release...

Asbury Automotive Group (ABG) closed out FY 2025 with Q4 revenue of US$4.7b, basic EPS of US$3.11 and net income of US$60m, alongside trailing twelve month revenue of US$18.0b and basic EPS of US$25.23. Over recent quarters the company has seen revenue move from US$4.5b in Q4 2024 to US$4.7b in Q4 2025. In the same period, quarterly EPS shifted from US$6.57 to US$3.11 as net income went from US$128.8m to US$60m. This has set up a results season where investors are weighing steady top line...

Cipher Mining (CIFR) has priced a US$2b senior secured notes offering to fund completion of its Black Pearl high performance computing data center in Texas, which is fully pre leased to Amazon Data Services for 15 years. See our latest analysis for Cipher Mining. The funding news follows a volatile period for the shares. A 1 day share price return of 15.98% contrasts with a 90 day share price return showing a 28.81% decline and a year to date share price return showing a 9.07% decline. At the...

Fabrinet (FN) has caught investors' attention after reporting a record second quarter, with revenue and earnings above its own guidance, supported by growth across optical communications, telecom and high performance computing. See our latest analysis for Fabrinet. The latest record quarter and fresh guidance appear to be feeding directly into Fabrinet’s momentum, with a 13.84% 1 day share price return taking the stock to $503.99 and a very large 5 year total shareholder return of 474.02%...

KKR (KKR) closed out FY 2025 with Q4 revenue of US$7.9b and basic EPS of US$1.24, alongside net income of US$1.1b, putting the focus squarely on how efficiently those fees and investment results are translating into profits. Over the past few quarters, revenue has moved from US$4.5b in Q1 2025 to US$7.1b in Q3 and then US$7.9b in Q4, while basic EPS shifted from a loss of US$0.22 in Q1 to US$0.97 in Q3 and US$1.24 in Q4. This progression gives investors a clearer view of how the earnings run...

Crown Castle (NYSE:CCI) is selling its small cell and fiber businesses as it reshapes into a U.S. tower focused REIT. The company is cutting roughly 20% of its workforce as part of a broader cost reduction effort. Crown Castle has filed legal action against DISH to recover a multi billion dollar amount after DISH defaulted on payment obligations and the related agreement was terminated. Crown Castle is refocusing on its core tower portfolio at a time when its share price is $80.88 and its...

If you are wondering whether Madison Square Garden Sports is fairly priced or out of line with its fundamentals, you are not alone. This stock often catches the eye of investors trying to understand what they are really paying for. The share price closed at US$279.29 recently, with returns of a 1.5% decline over 7 days, 9.2% over 30 days, 7.9% year to date, 36.0% over 1 year, 49.4% over 3 years, and 63.2% over 5 years. These figures may prompt questions about how much optimism or risk is...

International Flavors & Fragrances Inc. recently attracted attention as analysts grew more optimistic ahead of its December 2025 quarter results, expecting a year-over-year earnings decline on lower revenue but still anticipating a potential earnings beat. This shift in sentiment is underpinned by the company’s record of topping earnings-per-share estimates in each of the last four quarters, which has strengthened expectations for another positive surprise. We will now explore how this...

McEwen (MUX) is back in focus after reporting new drill results at its Gold Bar Mine Complex in Nevada, including its best hole so far at the Windfall deposit, and outlining further exploration plans. See our latest analysis for McEwen. The latest drill update comes after a strong run in McEwen’s share price, with a 57.29% 90 day share price return and very large 1 year total shareholder return. This suggests investors are reacting positively to both recent news and the broader gold story. If...